A Patient-Relevant Measurement Strategy to Assess Clinical Benefit of Novel Therapies for Non-metastatic Cutaneous Squamous Cell Carcinoma

Abstract Introduction Although cutaneous squamous cell carcinoma (CSCC) is the second most common type of skin cancer, research describing the patient experience is limited. This study sought to create a conceptual model of non-metastatic disease, to assess patient-reported outcome (PRO) instruments...

Full description

Saved in:
Bibliographic Details
Main Authors: Diana Rofail, Anna Ciesluk, Teya Lovell, Patrick Marquis, Matthew G. Fury, Chieh-I Chen
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-10-01
Series:Oncology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40487-024-00304-4
Tags: Add Tag
No Tags, Be the first to tag this record!